Co-Diagnostics, Inc. Deferred Revenue
Co-Diagnostics, Inc. (CODX) had Deferred Revenue of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-03-31
- 2025-12-31: Deferred Revenue $0.00.
- 2025-09-30: Deferred Revenue $40.86K.
- 2025-06-30: Deferred Revenue $40.86K.
- 2025-03-31: Deferred Revenue $100.00K.
| Period end | Deferred Revenue | Deferred Revenue as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2025-09-30 | $40.86K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $40.86K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $40.86K 10-K · filed 2026-03-31 | $100.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $40.86K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $127.71K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $300.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $300.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |